Related trials
SPIRIT IV, 2010 - everolimus ES vs paclitaxel ES
SORT-OUT-3, 2010 - zotarolimus ES vs sirolimus ES
ISAR-DESIRE-2, 2010 - sirolimus ES vs paclitaxel ES
RESOLUTE, 2010 - zotarolimus ES vs everolimus ES
ZEST (vs PES), 2009 - zotarolimus ES vs paclitaxel ES
PASEO, 2009 - drug ES vs bare-metal stent
Thiele, 2009 - sirolimus ES vs MIDCAB
ISAR TEST 2 (vs ZES), 2009 - dual sirolimus, probucol ES vs zotarolimus ES
ISAR TEST 3 (PF), 2009 - polymer free sirolimus stent vs sirolimus ES
ENDEAVOR IV, 2009 - zotarolimus ES vs paclitaxel ES
GENIUS-STEMI, 2009 - Genous stent vs bare-metal stent
ZEST AMI (vs PES), 2009 - zotarolimus ES vs paclitaxel ES
STICH (ventricular reconstruction), 2009 - CABG+surgical ventricular reconstruction vs CABG
ISAR TEST 2 (vs SES), 2009 - dual sirolimus, probucol ES vs sirolimus ES
COMPARE, 2009 - everolimus ES vs paclitaxel ES
ISAR TEST 3 (BP), 2009 - biodegradable-polymer sirolimus stent vs sirolimus ES
ZEST (vs SES), 2009 - zotarolimus ES vs sirolimus ES
ZEST AMI (vs SES), 2009 - zotarolimus ES vs sirolimus ES
BARI 2D, 2009 - CABG or PCI vs medical treatment
DEBATER (SES vs BMS), 2009 - sirolimus ES vs bare-metal stent
ISAR-TEST-4, 2009 - sirolimus biodegradable polymer vs sirolimus ES
SYNTAX, 2009 - paclitaxel ES vs CABG
ISAR-LEFT-MAIN, 2009 - sirolimus ES vs paclitaxel ES
Kim, 2008 - sirolimus ES vs paclitaxel ES
MISSION, 2008 - sirolimus ES vs bare-metal stent
See also:
All coronary artery disease clinical trials
All stable angina clinical trials
All clinical trials of revascularization with drug eluting stent
All clinical trials of paclitaxel ES
|
|
FRE-RACE study, 0
|
|
[NCT00130546]
Ongoing trial
|
Treatments
| Studied treatment |
Cypher select
|
| Control treatment |
Taxus
|
Patients
| Patients |
de novo native coronary lesions with two or more coronary artery stenoses |
Method and design
| Randomized effectives |
NA / NA (studied vs. control) |
| Design |
Cross over |
Results
No results available for this trial
- no clinical endpoint reported
Reference(s)
|